Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.numecd.2021.04.012 http://scihub22266oqcxt.onion/10.1016/j.numecd.2021.04.012 34039507!8064812!34039507     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nutr+Metab+Cardiovasc+Dis 2021 ; 31 (7): 2151-2155 Nephropedia Template TP {{tp|p=34039507|t=2021. COVID-19 vaccination in pregnant and lactating diabetic women |pdf=|usr=}}{{34039507}} gab.com Text COVID-19 vaccination in pregnant and lactating diabetic women JO: Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=34039507 #FOAvip AIM: To discuss available information on the opportunity for pregnant women affected by diabetes/obesity to receive COVID-19 vaccine. DATA SYNTHESIS: Pregnant women with SARS-CoV-2 (COVID-19) infection are at high risk for severe acute respiratory syndrome and adverse outcomes. Pregnant women with severe COVID-19 present increased rates of preterm delivery (<37 gestational weeks), cesarean delivery and neonatal admissions to the intensive care unit. Comorbidity such as diabetes (pregestational or gestational) or obesity further increased maternal and fetal complications. It is known that diabetic or obese patients with COVID-19 present an unfavorable course and a worse prognosis, with a direct association between worse outcome and suboptimal glycol-metabolic control or body mass index (BMI) levels. Critical COVID-19 infection prevention is important for both mother and fetus. Vaccination during pregnancy is a common practice. Vaccines against COVID-19 are distributed across the world with some population considered to have a priority. Since pregnant women are excluded from clinical trials very little information are available on safety and efficacy of COVD-19 vaccines during pregnancy. However, it is well known the concept of passive immunization of the newborn obtained with transplacental passage of protective antibodies into the fetal/neonatal circulation after maternal infection or vaccination. Moreover, it has been reported that COVID-19 vaccine-induced IgG pass to the neonates through breastmilk. Therefore, maternal vaccination can protect mother, fetus and baby. CONCLUSIONS: After an individual risk/benefit evaluation pregnant and lactating women should be counselled to receive COVID-19 vaccines. Twit Text FOAVip COVID-19 vaccination in pregnant and lactating diabetic women ????Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=34039507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34039507 #FOAvip English Wikipedia <ref>{{Cite pmid|34039507}}</ref> COVID-19 vaccination in pregnant and lactating diabetic women #MMPMID34039507 Sculli MA; Formoso G; Sciacca L Nutr Metab Cardiovasc Dis 2021[Jun]; 31 (7): 2151-2155 PMID34039507show ga AIM: To discuss available information on the opportunity for pregnant women affected by diabetes/obesity to receive COVID-19 vaccine. DATA SYNTHESIS: Pregnant women with SARS-CoV-2 (COVID-19) infection are at high risk for severe acute respiratory syndrome and adverse outcomes. Pregnant women with severe COVID-19 present increased rates of preterm delivery (<37 gestational weeks), cesarean delivery and neonatal admissions to the intensive care unit. Comorbidity such as diabetes (pregestational or gestational) or obesity further increased maternal and fetal complications. It is known that diabetic or obese patients with COVID-19 present an unfavorable course and a worse prognosis, with a direct association between worse outcome and suboptimal glycol-metabolic control or body mass index (BMI) levels. Critical COVID-19 infection prevention is important for both mother and fetus. Vaccination during pregnancy is a common practice. Vaccines against COVID-19 are distributed across the world with some population considered to have a priority. Since pregnant women are excluded from clinical trials very little information are available on safety and efficacy of COVD-19 vaccines during pregnancy. However, it is well known the concept of passive immunization of the newborn obtained with transplacental passage of protective antibodies into the fetal/neonatal circulation after maternal infection or vaccination. Moreover, it has been reported that COVID-19 vaccine-induced IgG pass to the neonates through breastmilk. Therefore, maternal vaccination can protect mother, fetus and baby. CONCLUSIONS: After an individual risk/benefit evaluation pregnant and lactating women should be counselled to receive COVID-19 vaccines. |*Lactation[MESH] |*Vaccination/adverse effects[MESH] |Antibodies, Viral/blood[MESH] |Biomarkers/blood[MESH] |Blood Glucose/*metabolism[MESH] |Body Mass Index[MESH] |COVID-19 Vaccines/*administration & dosage/adverse effects[MESH] |COVID-19/immunology/*prevention & control/virology[MESH] |Clinical Decision-Making[MESH] |Diabetes, Gestational/*blood/diagnosis/therapy[MESH] |Female[MESH] |Glycemic Control[MESH] |Humans[MESH] |Immunity, Maternally-Acquired[MESH] |Maternal-Fetal Exchange[MESH] |Milk, Human/immunology[MESH] |Pregnancy[MESH] |Pregnancy Complications, Infectious/blood/immunology/*prevention & control/virology[MESH] |Pregnancy in Diabetics/*blood/diagnosis/therapy[MESH] |Prenatal Care[MESH] |Risk Assessment[MESH] |Risk Factors[MESH]COVID-19 vaccination in pregnant and lactating diabetic women (epmc).pdf DeepDyve Pubget Overpricing